Evrofarma SA (ATH:EVROF)
3.660
-0.040 (-1.08%)
Jul 31, 2026, 4:50 PM EET
38.64% (1Y)
| Market Cap | 49.35M +36.7% |
| Revenue (ttm) | 49.44M +8.1% |
| Net Income | 3.53M +54.6% |
| EPS | 0.26 +54.7% |
| Shares Out | 13.67M |
| PE Ratio | 14.00 |
| Forward PE | n/a |
| Dividend | 0.06 (1.62%) |
| Ex-Dividend Date | Sep 15, 2026 |
| Volume | 1,212 |
| Open | 3.700 |
| Previous Close | 3.700 |
| Day's Range | 3.600 - 3.700 |
| 52-Week Range | 2.380 - 4.070 |
| Beta | 0.71 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 25, 2026 |